Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Lumen Technologies Teams Up With Eminence Grey to Deliver Sovereign AI Infrastructure to US Clients

Lumen Technologies Teams Up With Eminence Grey to Deliver Sovereign AI Infrastructure to US Clients

MT newswireMT newswire2026/10/08 13:33

09:33 AM EDT, 10/08/2026 (MT Newswires) -- Lumen Technologies (LUMN) has formed a partnership with Eminence Grey that aims to provide sovereign artificial intelligence infrastructure for government agencies and enterprises, the two companies said Thursday. The partnership brings together Eminence Grey's sovereign AI platform and Lumen's physical infrastructure and programmable network, creating a secure foundation for distributed AI environments across the US, the companies said. Financial terms of the partnership were not disclosed.

09:33 AM EDT, 10/08/2026 (MT Newswires) -- Lumen Technologies (LUMN) has formed a partnership with Eminence Grey that aims to provide sovereign artificial intelligence infrastructure for government agencies and enterprises, the two companies said Thursday. The partnership brings together Eminence Grey's sovereign AI platform and Lumen's physical infrastructure and programmable network, creating a secure foundation for distributed AI environments across the US, the companies said. Financial terms of the partnership were not disclosed.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss